Sarcoidosis

Lynch JP 3rd. Computed tomographic scanning in sarcoidosis. Semin Respir Crit Care Med. 2003;24:393-418. Abstract

1. American Thoracic Society. Statement on sarcoidosis: joint statement of the American Thoracic Society (ATS), the European Respiratory Society (ERS) and the World Association of Sarcoidosis and Other Granulomatous Disorders (WASOG), adopted by the ATS Board of Directors and by the ERS Executive Committee, February 1999. Am J Respir Crit Care Med. 1999;160:736-755.Full text  Abstract

2. Rybicki BA, Iannuzzi MC, Frederick MM, et al. Familial aggregation of sarcoidosis: a case-control etiologic study of sarcoidosis (ACCESS). Am J Respir Crit Care Med. 2001;164:2085-2091.Full text  Abstract

3. Baughman RP, Teirstein AS, Judson MA, et al. Clinical characteristics of patients in a case control study of sarcoidosis. Am J Respir Crit Care Med. 2001;164:1885-1889.Full text  Abstract

4. Valeyre D, Soler P, Clerici C, et al. Smoking and pulmonary sarcoidosis: effect of cigarette smoking on prevalence, clinical manifestations, alveolitis, and evolution of the disease. Thorax. 1988;43:516-524. Abstract

5. Rothova A. Ocular involvement in sarcoidosis. Br J Ophthalmol. 2000;84;110-116.Full text  Abstract

6. Lynch JP 3rd. Computed tomographic scanning in sarcoidosis. Semin Respir Crit Care Med. 2003;24:393-418. Abstract

7. Varela-Lema L, Fernández-Villar A, Ruano-Ravina A. Effectiveness and safety of endobronchial ultrasound-transbronchial needle aspiration: a systematic review. Eur Respir J. 2009;33:1156-1164.Full text  Abstract

8. National Institute for Health and Care Excellence. Endobronchial ultrasound-guided transbronchial needle aspiration for mediastinal masses. February 2008. http://www.nice.org.uk/ (last accessed 30 August 2017).Full text

9. Agarwal R, Srinivasan A, Aggarwal AN, et al. Efficacy and safety of convex probe EBUS-TBNA in sarcoidosis: a systematic review and meta-analysis. Respir Med. 2012;106:883-892. Abstract

10. Nunes H, Brillet PY, Valeyre D, et al. Imaging in sarcoidosis. Semin Respir Crit Care Med. 2007;28:102-120. Abstract

11. Youssef G, Leung E, Mylonas I, et al. The use of 18F-FDG PET in the diagnosis of cardiac sarcoidosis: a systematic review and metaanalysis including the Ontario experience. J Nucl Med. 2012;53:241-248. Abstract

12. Nobuhiro T, Atsuko T, Yoshikazu N, et al. Heterogeneous myocardial FDG uptake and the disease activity in cardiac sarcoidosis. JACC Cardiovasc Imaging. 2010;3:1219-1228. Abstract

13. Devine ST, Delgado JA, Lippmann ML. Hemoptysis as an initial presentation in sarcoidosis: How common is it?: a review. Clin Pulm Med. 2007;14:76-81.

14. de Kleijn WP, De Vries J, Lower EE, et al. Fatigue in sarcoidosis: a systematic review. Curr Opin Pulm Med. 2009;15:499-506. Abstract

15. Hirose Y, Ishida Y, Hayashida K, et al. Myocardial involvement in patients with sarcoidosis. An analysis of 75 patients. Clin Nucl Med. 1994;19:522-526. Abstract

16. Bianco A, Spiteri MA. Peripheral anergy and local immune hyperactivation in sarcoidosis: a paradox or birds of a feather. Clin Exp Immunol. 1997;110:1-3.Full text  Abstract

17. Murdoch J, Muller NL. Pulmonary sarcoidosis: changes on follow-up CT examination. AJR Am J Roentgenol. 1992;159:473-477.Full text  Abstract

18. Bradley B, Branley HM, Egan JJ, et al. Interstitial lung disease guideline: the British Thoracic Society in collaboration with the Thoracic Society of Australia and New Zealand and the Irish Thoracic Society. Thorax. 2008;63(suppl 5):v1-v58. Abstract

19. Sharma OP. Vitamin D, calcium, and sarcoidosis. Chest. 1996;109:535-539. Abstract

20. Agarwal R, Aggarwal AN, Gupta D. Efficacy and safety of conventional transbronchial needle aspiration in sarcoidosis: a systematic review and meta-analysis. Respir Care. 2013;58:683-693.Full text  Abstract

21. von Bartheld MB, Dekkers OM, Szlubowski A, et al. Endosonography vs conventional bronchoscopy for the diagnosis of sarcoidosis: the GRANULOMA randomized clinical trial. JAMA. 2013;309:2457-2464.Full text  Abstract

22. Royal College of Radiologists; Royal College of Physicians of London. Evidence-based indications for the use of PET-CT in the United Kingdom 2016. 2016. http://www.rcr.ac.uk (last accessed 30 August 2017).Full text

23. Kennedy CC, Limper AH. Redefining the clinical spectrum of chronic pulmonary histoplasmosis: a retrospective case series of 46 patients. Medicine (Baltimore). 2007;86:252-258. Abstract

24. Meyer KC. Beryllium and lung disease. Chest. 1994;106:942-946. Abstract

25. Fink JN, Ortega HG, Reynolds HY, et al. Needs and opportunities for research in hypersensitivity pneumonitis. Am J Respir Crit Care Med. 2005;171:792-798.Full text  Abstract

26. Facco M, Trentin L, Nicolardi L, et al. T cells in the lung of patients with hypersensitivity pneumonitis accumulate in a clonal manner. J Leukoc Biol. 2004;75:798-804. Abstract

27. Scadding JG. Prognosis of intrathoracic sarcoidosis in England: a review of 136 cases after five years' observation. Br Med J. 1961;2:1165-1172.Full text  Abstract

28. Paramothayan NS, Lasserson TJ, Jones P. Corticosteroids for pulmonary sarcoidosis. Cochrane Database Syst Rev. 2005;(2):CD001114.Full text  Abstract

29. Alberts C, van der Mark TW, Jansen HM; Dutch Study Group on Pulmonary Sarcoidosis. Inhaled budesonide in pulmonary sarcoidosis: a double-blind, placebo-controlled study. Eur Respir J. 1995;8:682-688.Full text  Abstract

30. Yeap SS, Hosking DJ. Management of corticosteroid-induced osteoporosis. Rheumatology. 2002;41:1088-1094.Full text  Abstract

31. Trulock EP, Edwards LB, Taylor DO, et al. The Registry of the International Society for Heart and Lung Transplantation: twenty-first official adult lung and heart-lung transplant report - 2004. J Heart Lung Transplant. 2004;23:804-815. Abstract

32. Khatri KA, Chotzen VA, Burrall BA. Lupus pernio: successful treatment with a potent topical corticosteroid. Arch Dermatol. 1995;131:617-618. Abstract

33. Jones E, Callen JP. Hydroxychloroquine is effective therapy for control of cutaneous sarcoidal granulomas. J Am Acad Dermatol. 1990;23:487-489. Abstract

34. Sharma OP, Sharma AM. Sarcoidosis of the nervous system. A clinical approach. Arch Intern Med. 1991;151:1317-1321. Abstract

35. Baughman RP, Drent M, Kavuru M, et al. Infliximab therapy in patients with chronic sarcoidosis and pulmonary involvement. Am J Respir Crit Care Med. 2006;174:795-802.Full text  Abstract

36. Baughman RP, Judson MA, Teirstein AS, et al. Thalidomide for chronic sarcoidosis. Chest. 2002;122:227-232. Abstract

37. Droitcourt C, Rybojad M, Porcher R, et al. A randomized, investigator-masked, double-blind, placebo-controlled trial on thalidomide in severe cutaneous sarcoidosis. Chest. 2014;146:1046-1054. Abstract

38. Zabel P, Entzian P, Dalhoff K, et al. Pentoxifylline in treatment of sarcoidosis. Am J Respir Crit Care Med. 1997;155:1665-1669. Abstract

39. Baughman RP, Culver DA, Cordova FC, et al. Bosentan for sarcoidosis-associated pulmonary hypertension: a double-blind placebo controlled randomized trial. Chest. 2014;145:810-817. Abstract

40. Corte TJ, Wells AU, Nicholson AG, et al. Pulmonary hypertension in sarcoidosis: a review. Respirology. 2011;16:69-77. Abstract

41. Stern BJ. Neurological complications of sarcoidosis. Curr Opin Neurol. 2004;17:311-316. Abstract

42. Baughman RP, Lower EE. Fungal infections as a complication of therapy for sarcoidosis. QJM. 2005;98:451-456.Full text  Abstract